by | Feb 3, 2025 | Lupus Foundation of America, News & Events
The Centers for Medicare and Medicaid Services (CMS) issued final payment determinations for Progentec Diagnostics’ proprietary tests, the aiSLE DX Flare Risk Index (FRI) and aiSLE DX Disease Activity Index (DAI) biomarker tests. Starting on January 1, 2025, Medicare...
by | Feb 1, 2025 | Lupus Foundation of America
Nyobie’s journey with lupus is a story of resilience, empowerment, and the transformative strength of finding her voice. Diagnosed in 2010 after a difficult 19-year journey through eight different doctors, Nyobie has lived through the complexities of a chronic illness...
by | Jan 30, 2025 | Lupus Foundation of America
The way we talk about lupus – to ourselves and with others – matters. Living with lupus can feel like a daily battle filled with uncertainty. Negative self-talk about this disease and its limitations can only weigh you down and make you feel worse. In our final blog...
by | Jan 24, 2025 | Lupus Foundation of America
On November 3rd, I ran the New York City Marathon. It was difficult, extraordinary, emotional and painful – not in the least because it was almost 3 years to the day that I got diagnosed with lupus.I’d argue that running a marathon is an extraordinary accomplishment...
by | Jan 24, 2025 | Lupus Foundation of America
This month we have been discussing mental health and wellness when you have lupus in a four-part blog series. This week we are sharing some strategies on talking about lupus and your experiences.Talking with friends, family and colleagues about living with lupus isn’t...
by | Jan 24, 2025 | Lupus Foundation of America, News & Events
An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE) and lupus nephritis (LN). The trial, named the CARAMEL trial,...
